BiomarkersHumans4,719 participantsCohort study

Larger lung artery volume tied to deaths in smokers without COPD

Each roughly 25-millilitre increase in artery volume was linked to a death-rate ratio of 1.42 in one cohort and 1.23 in another.

Lungs with broad branching blood vessels sit beside a smaller pair with slimmer vessels and a chest cross-section showing lungs and vessel sections.

Respiratory Medicine

Researchers studied 4,719 current and former smokers without chronic obstructive pulmonary disease, a long-term lung condition that restricts airflow. Their retrospective observational analysis used data collected in a cohort study. They checked the findings in another cohort of 3,391 people without the disease. The groups had median ages of 56 and 64, respectively.

An automated method measured the volume of the pulmonary artery outside lung tissue on chest scans. This artery carries blood from the heart to the lungs. Larger volumes were associated with deaths from any cause after accounting for age, smoking exposure and other health factors. The death-rate ratios describe relative rates during follow-up; values above one indicate higher rates.

Why it matters

Survival among middle-aged and older smokers bears on lifespan. The researchers suggested artery volume could be a candidate marker for selecting groups in studies of lung blood-vessel disease.

Caveats

This retrospective observational analysis cannot show that larger artery volumes caused deaths. The proposed imaging marker still needs validation in studies that follow people forward in time.

The paper

Pulmonary arterial volume and mortality in smokers without chronic obstructive pulmonary disease

Shanshan Wang, Mehran Azimbagirad, Daryl O Cheng,
Show 20 more authorsTanya Patrick, Amyn Bhamani, Robert Chapman, Daisuke Yamada, Arjun Nair, Gabrielle Baxter, Ashkan Pakzad, Adam Szmul, Bojidar Rangelov, Jason Lim, Vichayasit Tantayapong, David A Lynch, Gregory L Kinney, Joanna Pepke-Zaba, Hakim Ghani, Caitlin Fermoyle, Daniel C Alexander, SUMMIT Consortium, Sam M Janes, John R Hurst,
Joseph Jacob

University College London

Respiratory Medicine · 6 Oct 2026

doi.org/10.1016/j.rmed.2026.109134PubMed 42838239